Bellafill® vs. Sculptra™ nodules
Posted:11:02 a.m. Monday, Nov. 17, 2014
By Anita Mandal, M.D.
Question: I was happy with the Sculptra treatment for my cheeks a year ago but recently got bumps. My plastic surgeon said it’s a delayed reaction to Sculptra which has a 19% chance of nodules. He treated the nodules which went away. I want cheek fillers again, but am afraid to get more Sculptra. Is there a better option?
Answer: While Sculptra is a quality filler, it’s true that the average granuloma rate is 19 percent. However, this risk can be much, much lower depending on the surgeon’s skill and experience.
Compared to Sculptra, Bellafill® has a granuloma rate of about 1 percent or less. If you had nodules from Sculptra and don’t want to take that chance again, Bellafill® is good option since it lasts much longer and has a lower risk of lump formation.
Even though both Bellafill® and Sculptra are collagen stimulators, they are completely different products. If you’ve had a reaction to one, it does not mean you will react to the other.
The lower granuloma rate of Bellafill® is believed to be due to its advanced micro-sphere technology. Bellafill®’s proprietary formulation makes it a very uniform mixture with more even distribution within the tissues. Sculptra, on the other hand, is more prone to uneven tissue distribution and nodules.
Temporary fillers such as Voluma, Juvederm, Perlane and Radiesse can also improve cheek hollows. However, these temporary fillers can be very costly over the long run due to their frequent maintenance. While Bellafill® may cost more than Sculptra and other temporary fillers, it is more cost-effective for facial hollowing due to it’s long duration.
Careful consultation with a Board Certified Facial Plastic Surgeon to assess your facial rejuvenation needs is the first step.